Vimarsana
Biggest News Aggregation in the World

Bone Sarcoma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bone Sarcoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bone Sarcoma Today - Breaking & Trending Today

Eftilagimod Alpha Novel Triplet Combination is Well Tolerated, Generates CRs in Soft Tissue Sarcoma - Vimarsana News

Eftilagimod Alpha Novel Triplet Combination is Well Tolerated, Generates CRs in Soft Tissue Sarcoma

Eftilagimod alpha plus radiotherapy and pembrolizumab was safe and displayed initial activity in soft tissue sarcoma.

Study Sees Limited Success for Extrapleural Pneumonectomy in Sarcoma Cases - Vimarsana News

Study Sees Limited Success for Extrapleural Pneumonectomy in Sarcoma Cases

In this retrospective analysis, outcomes data were evaluated on patients receiving care related to extrapleural pneumonectomy for soft tissue sarcoma or bone sarcoma.

Source: ajmc.com
AI 'nearly twice as accurate' as biopsies at grading some sarcomas - Vimarsana News

AI 'nearly twice as accurate' as biopsies at grading some sarcomas

Tests comparing artificial intelligence and standard biopsies revealed that AI had an 86% greater success rate than its competitor, suggests new researc...

AI Could Revolutionize Cancer Care By Detecting High-Risk Tumors More Accurately - Vimarsana News

AI Could Revolutionize Cancer Care By Detecting High-Risk Tumors More Accurately

A recent study conducted by the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research (ICR) highlights AI's capabilities in assessing cancer aggressiveness.

AI algorithm 'could improve outcomes for thousands of cancer patients a year' | Dumbarton and Vale of Leven Reporter - Vimarsana News

AI algorithm 'could improve outcomes for thousands of cancer patients a year' | Dumbarton and Vale of Leven Reporter

Researchers have developed an algorithm that predicts how aggressive a tumour is likely to be more accurately than a biopsy.